This federal contract award, valued at $2,905.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Lyrica 300 mg capsules, a medication used for the treatment of neuropathic pain, nerve pain, and fibromyalgia. The contract has an ultimate completion date of December 30, 2024 and is a Firm Fixed Price arrangement.
This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/30/25, 12:49 AM